Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871 (Q66078243)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871 |
clinical trial |
Statements
A Phase IIa, Randomised, Multi-Centre, Double-Blind, Placebo-Controlled, 3 Periods, Crossover Study to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Inhaled AZD8871 Administered Once Daily for 2 Weeks in Patients With Moderate to Severe COPD. (English)
0 references
15 December 2016
0 references
18 August 2017
0 references
42
0 references
40 year
0 references
80 year
0 references